Journal
SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-28003-x
Keywords
-
Categories
Funding
- Centre National de la Recherche Scientifique [UMR 7369]
- University of Reims Champagne-Ardenne
- Conference de Coordination Interregionale de la Ligue Contre le Cancer du Grand Est (CCIR-GE)
- HPC-Regional Center ROMEO
- Multiscale Molecular Modeling Platform (P3M)
- Flow Cytometry Core URCACyt of the University of Reims Champagne-Ardenne (France)
Ask authors/readers for more resources
Tetrastatin, a 230 amino acid sequence from collagen IV, was previously demonstrated to inhibit melanoma progression. In the present paper, we identified the minimal active sequence (QKISRCQVCVKYS: QS-13) that reproduced the anti-tumor effects of whole Tetrastatin in vivo and in vitro on melanoma cell proliferation, migration and invasion. We demonstrated that QS-13 binds to SK-MEL-28 melanoma cells through the alpha(v)beta(3) integrin using blocking antibody and beta 3 integrin subunit siRNAs strategies. Relevant QS-13 conformations were extracted from molecular dynamics simulations and their interactions with alpha(v)beta 3 integrin were analyzed by docking experiments to determine the binding areas and the QS-13 amino acids crucial for the binding. The in silico results were confirmed by in vitro experiments. Indeed, QS-13 binding to SK-MEL-28 was dependent on the presence of a disulfide-bound as shown by mass spectroscopy and the binding site on alpha(v)beta(3) was located in close vicinity to the RGD binding site. QS-13 binding inhibits the FAK/PI3K/Akt pathway, a transduction pathway that is largely involved in tumor cell proliferation and migration. Taken together, our results demonstrate that the QS-13 peptide binds alpha(v)beta(3) integrin in a conformation-dependent manner and is a potent antitumor agent that could target cancer cells through alpha(v)beta(3).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available